Sjogren's syndrome: evolving therapies

RI Fox - Expert Opinion on Investigational Drugs, 2003 - Taylor & Francis
Sjogren's syndrome (keratoconjunctivis sicca) is a relatively common disorder with
incidence of∼ 0.5% of adult women. It has both local (ocular and oral) features as well as …

Pathogenesis and treatment of Sjogren's syndrome: review and update

Q Zhan, J Zhang, Y Lin, W Chen, X Fan… - Frontiers in …, 2023 - frontiersin.org
Sjogren's syndrome (SS) is a chronic autoimmune disease accompanied by multiple
lesions. The main manifestations include dryness of the mouth and eyes, along with …

Sjogren's syndrome: an update on clinical, basic and diagnostic therapeutic aspects

AG Tzioufas, PG Vlachoyiannopoulos - Journal of autoimmunity, 2012 - Elsevier
The 11th International Symposium for Sjogren's syndrome was held in Athens, Greece in
September 2011. This symposia is part of a long series of meetings that have attempted to …

Biologics in the treatment of Sjogren's syndrome, systemic lupus erythematosus, and lupus nephritis

S Narain, N Berman, R Furie - Current Opinion in Rheumatology, 2020 - journals.lww.com
Biologics in the treatment of Sjogren's syndrome, systemic l... : Current Opinion in
Rheumatology Biologics in the treatment of Sjogren's syndrome, systemic lupus …

Conventional therapy of Sjogren's syndrome

CP Mavragani, HM Moutsopoulos - Clinical reviews in allergy & …, 2007 - Springer
Sjogren's syndrome (SS) is a chronic autoimmune disorder affecting mainly middle-aged
women. It is characterized by lymphocytic infiltration and destruction of the exocrine glands …

Advances in the diagnosis and treatment of Sjogren's syndrome

X Chen, H Wu, W Wei - Clinical rheumatology, 2018 - Springer
Sjogren's syndrome (SS) is a systemic autoimmune disease that primarily affects the
exocrine glands, resulting in dryness of the eyes and mouth due to lymphocytic infiltration of …

Use of biologics in Sjögren's syndrome

G Nocturne, D Cornec, R Seror… - Rheumatic Disease …, 2016 - rheumatic.theclinics.com
The management of patients with primary Sjogren syndrome (pSS) has long suffered from
the lack of effective treatments. Progress made in the understanding of pSS pathogenesis …

[引用][C] Living With Sjögren Disease: Prospects for Disease‐Modifying Therapies

EW St. Clair - Arthritis & Rheumatology - Wiley Online Library
Living with Sjӧgren's disease (SjD), or Sjӧgren's syndrome or simply Sjӧgren's, is mostly
about learning to cope with physical tiredness, dryness, and joint pain. It is predominantly …

Emerging treatment strategies and potential therapeutic targets in primary Sjogren's syndrome

H Becker, H Pavenstaedt… - Inflammation & Allergy …, 2010 - ingentaconnect.com
Primary Sjogren's syndrome (pSS) is a common autoimmune disease which can lead to
considerable complications and diminished quality of life. Recent insights into disease …

Primary Sjogren's syndrome: current and prospective therapies

A Thanou-Stavraki, JA James - Seminars in arthritis and rheumatism, 2008 - Elsevier
OBJECTIVE: To summarize data on existing and experimental therapies for primary
Sjogren's syndrome (pSS), referring both to sicca syndrome and to other systemic disease …